Cargando…

Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda

OBJECTIVES: To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA. We compared characteristics of women using DMPA-SC with those of other modern methods,...

Descripción completa

Detalles Bibliográficos
Autores principales: Anglewicz, Philip, Larson, Elizabeth, Akilimali, Pierre, Guiella, Georges, Kayembe, Patrick, Kibira, Simon P.S., Makumbi, Fredrick, Radloff, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846921/
https://www.ncbi.nlm.nih.gov/pubmed/33554107
http://dx.doi.org/10.1016/j.conx.2021.100055
_version_ 1783644833943912448
author Anglewicz, Philip
Larson, Elizabeth
Akilimali, Pierre
Guiella, Georges
Kayembe, Patrick
Kibira, Simon P.S.
Makumbi, Fredrick
Radloff, Scott
author_facet Anglewicz, Philip
Larson, Elizabeth
Akilimali, Pierre
Guiella, Georges
Kayembe, Patrick
Kibira, Simon P.S.
Makumbi, Fredrick
Radloff, Scott
author_sort Anglewicz, Philip
collection PubMed
description OBJECTIVES: To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA. We compared characteristics of women using DMPA-SC with those of other modern methods, and identified the extent to which women using DMPA-SC switched from another method or are first-time users of contraception. STUDY DESIGN: We used data collected by the Performance Monitoring for Action (PMA) Project between 2016 and 2019 from three countries, Burkina Faso, Democratic Republic of Congo, and Uganda. We tabulated characteristics of DMPA-SC, DMPA-IM, implant, and male condom users, and used multivariate analysis to compare characteristics of women using DMPA-SC those of the other three methods. We also examined previous contraceptive method use (if any) among women currently using DMPA-SC. RESULTS: We found that never-married women were more likely to use male condoms instead of DMPA-SC. Women with two or more children (compared to no children or one child) were more likely to use implants instead of DMPA-SC in both Uganda and DRC. DMPA-SC was the first method used by the majority of current users in Burkina Faso and Uganda. DMPA-SC users who previously used another method generally switched from less effective methods. CONCLUSIONS: Although the characteristics of women using DMPA-SC varied across countries, DMPA-SC appears to be reaching new populations of women instead of inspiring existing modern users to switch to DMPA-SC, and appears to be appealing to first time users of contraception. IMPLICATIONS: It appears that DMPA-SC appeals to new contraceptive users in sub-Saharan Africa, which implies that DMPA-SC may have the potential to increase modern contraceptive prevalence in sub-Saharan African countries.
format Online
Article
Text
id pubmed-7846921
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78469212021-02-04 Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda Anglewicz, Philip Larson, Elizabeth Akilimali, Pierre Guiella, Georges Kayembe, Patrick Kibira, Simon P.S. Makumbi, Fredrick Radloff, Scott Contracept X Article OBJECTIVES: To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA. We compared characteristics of women using DMPA-SC with those of other modern methods, and identified the extent to which women using DMPA-SC switched from another method or are first-time users of contraception. STUDY DESIGN: We used data collected by the Performance Monitoring for Action (PMA) Project between 2016 and 2019 from three countries, Burkina Faso, Democratic Republic of Congo, and Uganda. We tabulated characteristics of DMPA-SC, DMPA-IM, implant, and male condom users, and used multivariate analysis to compare characteristics of women using DMPA-SC those of the other three methods. We also examined previous contraceptive method use (if any) among women currently using DMPA-SC. RESULTS: We found that never-married women were more likely to use male condoms instead of DMPA-SC. Women with two or more children (compared to no children or one child) were more likely to use implants instead of DMPA-SC in both Uganda and DRC. DMPA-SC was the first method used by the majority of current users in Burkina Faso and Uganda. DMPA-SC users who previously used another method generally switched from less effective methods. CONCLUSIONS: Although the characteristics of women using DMPA-SC varied across countries, DMPA-SC appears to be reaching new populations of women instead of inspiring existing modern users to switch to DMPA-SC, and appears to be appealing to first time users of contraception. IMPLICATIONS: It appears that DMPA-SC appeals to new contraceptive users in sub-Saharan Africa, which implies that DMPA-SC may have the potential to increase modern contraceptive prevalence in sub-Saharan African countries. Elsevier 2021-01-20 /pmc/articles/PMC7846921/ /pubmed/33554107 http://dx.doi.org/10.1016/j.conx.2021.100055 Text en © 2021 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Anglewicz, Philip
Larson, Elizabeth
Akilimali, Pierre
Guiella, Georges
Kayembe, Patrick
Kibira, Simon P.S.
Makumbi, Fredrick
Radloff, Scott
Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
title Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
title_full Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
title_fullStr Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
title_full_unstemmed Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
title_short Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
title_sort characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (dmpa-sc) in burkina faso, democratic republic of congo, and uganda
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846921/
https://www.ncbi.nlm.nih.gov/pubmed/33554107
http://dx.doi.org/10.1016/j.conx.2021.100055
work_keys_str_mv AT anglewiczphilip characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda
AT larsonelizabeth characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda
AT akilimalipierre characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda
AT guiellageorges characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda
AT kayembepatrick characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda
AT kibirasimonps characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda
AT makumbifredrick characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda
AT radloffscott characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda